Astex Pharmaceuticals, Inc. (US)
Martin Sims has extensive experience in the pharmaceutical industry, with roles at companies such as Astex Pharmaceuticals, GlaxoSmithKline, and Apitope. Currently serving as the Senior Director of Translational Research at Astex Pharmaceuticals, Martin previously held positions such as Head Biologist Kinib DPU at GlaxoSmithKline and Research Director at Apitope. Additionally, Martin worked as the Director of External Discovery at GlaxoSmithKline.
This person is not in any offices
Astex Pharmaceuticals, Inc. (US)
Astex Pharmaceuticals, Inc. (“Astex”) is committed to the fight against cancer. Astex is developing a proprietary pipeline of novel therapies for the treatment of solid tumors and hematological malignancies. Astex is a member of the Otsuka group of pharmaceutical companies. The group also includes Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd and Taiho Oncology, Inc. Subject to regulatory approvals, Astex's products will be commercialized in the US and Canada by Taiho subsidiaries, and the rest of the world by Otsuka subsidiaries.